Clinical Trial Update: SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SHR-1701 in combination with chemotherapy for gastric adenocarcinoma or gastroesophageal junction adenocarcinoma with peritoneal metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• SHR-1701

Snippet

Sponsor: Ruijin Hospital | Conditions: Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING